WELLESLEY HILLS, Mass., April 6, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Source Precision Medicine, Inc., d/b/a Source MDx ("Source MDx") announced that Source Laboratory Information Management Systems (LIMS), Source Dynamics and Source Primer/Probe Database will be offered for sale on April 29, 2011.
The Primer/Probe database and software, for instance, is a user-friendly interface for the repository of all primer/probe related information from design, sequence information across multiple design versions to serial quality control test data. The software provides a secure and audit-friendly database that supports a metrics driven approval of reagents designed to meet specific performance characteristics.
Finn also stated that the patent number information announced in his March 21, 2011 press release was incorrect. Patent number 6,940,439 should have been stated as 6,960,439.
Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's office – email@example.com or 781-237-8840. They will then receive a bid package.
About Joseph F. Finn, Jr., C.P.A.
Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm Finn, Warnke & Gayton LLP of Wellesley Hills, Massachusetts (www.finnwarnkegayton.com). He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as Assignment for the Benefit of Creditors and Liquidating Agent for corporations. He has been involved in a number of loan workouts and bankruptcy cases for thirty-six (36) years. His most recent Assignments for the Benefit of Creditors in the biotech filed include Spherics, Inc., ActivBiotics, Inc., Prospect Therapeutics, Inc. and Epix Pharmaceuticals, Inc.
For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840.
SOURCE Joseph F. Finn, Jr., C.P.A.